Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment
| Conditions: | Malignant Epithelial Mesothelioma|Adenocarcinoma of the Pancreas|Carcinoma, Non-Small-Cell Lung|Adenocarcinoma of the Ovaries |
| Start Date: | December 1, 2007 |
| Phase: | Phase I |
| Status: | Terminated |
| NCT ID: | NCT00585845 |
| Study Type: | Interventional |
| Intervention: | Biological: CRS-207, Live-attenuated Listeria monocytogenes expressing human Mesothelin |
| Study Design: | Endpoint Classification: Safety Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Anza Therapeutics, Inc. |
| Ages: | Adult|Senior |
| Enrollment: | 17 |
| Funded By: | Industry |
| First Received: | December 22, 2007 |
| End Date: | February 1, 2009 |
| Last Updated: | February 19, 2009 |
| Last Verified: | February 1, 2009 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
